A role for beta-cell-expressed G protein-coupled receptor 119 in glycemic control by enhancing glucose-dependent insulin release. (full – 2007) http://endo.endojournals.org/content/148/6/2601.long
Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. (full – 2008) http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Endocannabinoids and nutrition. (full – 2008) http://onlinelibrary.wiley.com/doi/1...8.01687.x/full
GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Receptors for acylethanolamides-GPR55 and GPR119. (full – 2009) http://www.ncbi.nlm.nih.gov/pmc/arti...9/?tool=pubmed
GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. (full – 2009) http://www.ncbi.nlm.nih.gov/pmc/arti...2/?tool=pubmed
N-acylethanolamines, anandamide and food intake. (abst – 2009) http://www.ncbi.nlm.nih.gov/pubmed/19413995
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full – 2010) http://pharmrev.aspetjournals.org/co....full.pdf+html
N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119. (full – 2010) http://mend.endojournals.org/content/24/1/161.long
GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21094910
Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20937249
AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20816753
GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms (full – 2011) http://endo.endojournals.org/content...8-c46f78f293d9
The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423238/
G-Protein-Coupled Receptors in Intestinal Chemosensation (full – 2012) http://www.sciencedirect.com/science...50413112000198
Stimulating beta cell replication and improving islet graft function by GPR119 agonists. (full – 2012) http://onlinelibrary.wiley.com/doi/1...1.01332.x/full
GPR119 as a fat sensor. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22560300
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full – 2013) http://www.hindawi.com/journals/ije/2013/259676/
Cannabinoid receptor modulation of the endothelial cell inflammatory response (abst – 2013) http://www.jimmunol.org/cgi/content/...2-845dc670f7cf
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/1...bph.12560/full
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057719/
Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic Nacylethanolamines (full – 2014) http://www.plosone.org/article/info%...l.pone.0100365
Classical endocannabinoid-like compounds and their regulation by nutrients (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24677570
Endogenous and synthetic agonists of GPR119 differ in signalling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. (full – 2008) http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
Endocannabinoids and nutrition. (full – 2008) http://onlinelibrary.wiley.com/doi/1...8.01687.x/full
GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity (full - 2008) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Receptors for acylethanolamides-GPR55 and GPR119. (full – 2009) http://www.ncbi.nlm.nih.gov/pmc/arti...9/?tool=pubmed
GPR119 is essential for oleoylethanolamide-induced glucagon-like peptide-1 secretion from the intestinal enteroendocrine L-cell. (full – 2009) http://www.ncbi.nlm.nih.gov/pmc/arti...2/?tool=pubmed
N-acylethanolamines, anandamide and food intake. (abst – 2009) http://www.ncbi.nlm.nih.gov/pubmed/19413995
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full – 2010) http://pharmrev.aspetjournals.org/co....full.pdf+html
N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119. (full – 2010) http://mend.endojournals.org/content/24/1/161.long
GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/21094910
Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20937249
AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20816753
GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms (full – 2011) http://endo.endojournals.org/content...8-c46f78f293d9
The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423238/
G-Protein-Coupled Receptors in Intestinal Chemosensation (full – 2012) http://www.sciencedirect.com/science...50413112000198
Stimulating beta cell replication and improving islet graft function by GPR119 agonists. (full – 2012) http://onlinelibrary.wiley.com/doi/1...1.01332.x/full
GPR119 as a fat sensor. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22560300
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full – 2013) http://www.hindawi.com/journals/ije/2013/259676/
Cannabinoid receptor modulation of the endothelial cell inflammatory response (abst – 2013) http://www.jimmunol.org/cgi/content/...2-845dc670f7cf
Vascular targets for cannabinoids: animal and human studies. (full – 2014) http://onlinelibrary.wiley.com/doi/1...bph.12560/full
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057719/
Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic Nacylethanolamines (full – 2014) http://www.plosone.org/article/info%...l.pone.0100365
Classical endocannabinoid-like compounds and their regulation by nutrients (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24677570